Postdoctoral Position in cell matrix biology & antibody-drug conjugate (IRCM, INSERM U1194, Montpellier, France)

Publié le 22/02/24

Application deadline: 31 Mars 2024
Anticipated start date: ASAP 2024

The team (Breast cancer, Microenvironment and Immunotargeting) at Montpellier Cancer Research
Institute (France) is looking for a postdoctoral researcher to work on the optimization of antibodydrug
conjugates targeting matricellular proteins in breast cancer. This postdoctoral fellowship is part
of a priority research program and equipment (PEPR) ACCREDIA, which brings together a lab network
of seven academic partners funded by the French government to improve knowledge, skills and
methodologies in antibody development. The position is funded in the frame of French PEPR-PIA4
Accredia ANR-22-PEBI-0009 for a period of 2 to 3 years.



Retour à la liste générale

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés